MIPHARM SPA
Stefano Spiniello currently serves as Presidente del Collegio Sindacale at ISCOM SPA since July 2024 and holds the position of Partner and Tax Consultant at Studio Spiniello since March 2009. Spiniello is also a Cultore della materia in Diritto Finanziario at Università degli Studi di Napoli Federico II, a role maintained since May 2020. Additional responsibilities include serving as Sindaco effettivo for multiple companies such as Noovle, TENAX GROUP, 3b Latte, Mipharm S.p.A., Gias Spa, and Gruppo Pieralisi. In July 2024, Spiniello became a Consigliere di amministrazione at Rotofilm spa. Education includes participation in the SDA Director's Program at SDA Bocconi in November 2021 and a degree in CLELI, economia e legislazione per l'impresa from Università Bocconi, completed in 2007, with additional studies at Copenhagen Business School in 2004.
This person is not in the org chart
This person is not in any teams
MIPHARM SPA
Mipharm S.p.A. was born in January 1998 following the merger of Sandoz and Ciba Geigy, from which resulted the new company Novartis. Mipharm was founded by a group of ex managers coming from Novartis by mean of a spin-off of the manufacturing site located in Milan, Via Quaranta, previously owned by Sandoz. In December 2016, Mandarin Capital Partners II acquired the majority stake in Mipharm share capital. Today, Mipharm is one of the most valuable third party manufacturing and new product development sites in Italy and it claims to have four FDA approvals (Nasal Spray Solution, Oral Potent Drug, Sachet, Packaging). Mipharm has been investing significant resources to continuously improve manufacturing site qualitative standard and currently it is able to produce and to pack a huge range of products and pharmaceutical forms.